HLA-derived peptides in clinical trial for kidney allografts.
Featherstone
C
C
D000818:Animals; D017322:Clinical Trials, Phase II as Topic; D015395:Histocompatibility Antigens Class I / Q000737:chemistry / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000276:immunology*; D016030:Kidney Transplantation / Q000276:immunology*; D007694:Killer Cells, Natural / Q000276:immunology; D008958:Models, Molecular; D010455:Peptides / Q000276:immunology*; D014184:Transplantation, Homologous / Q000276:immunology*
D015395:Histocompatibility Antigens Class I; D007166:Immunosuppressive Agents; D010455:Peptides